BlackRock’s Beneficient BENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Buy
45,323
+702
+2% +$3.04K ﹤0.01% 4844
2025
Q4
$314K Buy
44,621
+43,488
+3,838% +$238K ﹤0.01% 4608
2025
Q3
$8.62K Sell
1,133
-9
-0.8% -$26 ﹤0.01% 5226
2025
Q2
$2.74K Hold
1,142
﹤0.01% 5308
2025
Q1
$2.86K Hold
1,142
﹤0.01% 5287
2024
Q4
$6.8K Sell
1,142
-217
-16% -$1.87K ﹤0.01% 5200
2024
Q3
$13.4K Hold
1,359
﹤0.01% 4974
2024
Q2
$24.1K Buy
1,359
+1
+0.1% +$33 ﹤0.01% 4987
2024
Q1
$58.2K Hold
1,358
﹤0.01% 4838
2023
Q4
$423K Hold
1,358
﹤0.01% 4463
2023
Q3
$2.25M Buy
+1,358
New +$2.13M ﹤0.01% 3952

Other funds holding BENF

BlackRock's BENF Position: Q1 2026 in Review

BlackRock increased its Beneficient (BENF) stake by 1.6% in Q1 2026, buying an estimated $3.04K and bringing the position to 45,323 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #4844.

BlackRock first reported a position in BENF in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.25M in Q3 2023. 14 funds tracked by Wall St. Rank hold BENF as of Q1 2026.

  • BlackRock held 45,323 shares of Beneficient worth $159K as of Q1 2026.
  • BlackRock bought 702 Beneficient shares in Q1 2026, an estimated $3.04K.
  • Beneficient made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4844 holding.
  • BlackRock first reported a position in Beneficient in Q3 2023 and has held it in 11 quarters since.
  • BlackRock's Beneficient position peaked at $2.25M in Q3 2023.
  • 14 funds tracked by Wall St. Rank held Beneficient as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.